Viridian Therapeutics

About:

Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.

Website: https://www.viridiantherapeutics.com

Twitter/X: ViridianThera

Top Investors: Hercules Capital, MRL Ventures Fund, Fidelity, Atlas Venture, JAFCO

Description:

Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.

Total Funding Amount:

$907M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)viridiantherapeutics.com

Hub Tags:

Pledge 1%

Founders:

Eric Newell Olson, William Marshall

Number of Employees:

51-100

Last Funding Date:

2024-09-11

IPO Status:

Public

© 2025 bioDAO.ai